title: [Results of treatment of lung cancer complicated by postoperative pleural empyema].
abstract: An evaluation of the literature and our own experience with surgical and combined treatment of lung cancer complicated by postoperative pleural empyema established the following incidence rates in 2.4% of patients: postpneumonectomy (4.2%), particularly on the side (57.4%), and in tumor stage III cases (70.6%). Bronchal stump failure (89.7%) was the main cause of postoperative pleural empyema while the risk doubled (4.5-6.0%; p < or = 0.05) after neoadjuvant therapy. Both immediate and end results were worse in postoperative pleural empyema than in similar uncomplicated cases: 12 month survival--43.8% vs. 71.1%; 3-year--18.8-36.8%; 5-year--10.4-26.3%. Also, postoperative pleural empyema patients stayed in hospital longer.
authors.forename: A I
authors.initials: AI
authors.lastname: Arsen'ev
authors.forename: A S
authors.initials: AS
authors.lastname: Barchuk
authors.forename: N Iu
authors.initials: NIu
authors.lastname: Aristidov
authors.forename: A A
authors.initials: AA
authors.lastname: Barchuk
authors.forename: Iu A
authors.initials: IuA
authors.lastname: Kulakova
authors.forename: A S
authors.initials: AS
authors.lastname: Klimov
authors.forename: S A
authors.initials: SA
authors.lastname: Tarkov
authors.forename: A O
authors.initials: AO
authors.lastname: Nefëdov
mesh_terms: D000368:Aged; D016724:Empyema, Pleural / Q000209:etiology*; D005260:Female; D006801:Humans; D015994:Incidence; D007902:Length of Stay; D008175:Lung Neoplasms / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D011013:Pneumonectomy / Q000009:adverse effects*; D016896:Treatment Outcome